Evidence map›Paper›PMID 33028885›Full record

ArticleScientific reports2020

Effects of fibrillin mutations on the behavior of heart muscle cells in Marfan syndrome.

Jeffrey Aalders, Laurens Léger, Louis Van der Meeren, Natasja Van den Vreken, Andre G Skirtach, Sanjay Sinha, Julie De Backer, Jolanda van Hengel

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Human stem cell models for Marfan syndrome: aFrontiers in cell and developmental biology · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jeffrey AaldersMedical Cell Biology Research Group, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Corneel Heymanslaan 10, Building B, Entrance 36, 9000, Ghent, Belgium.
Laurens LégerMedical Cell Biology Research Group, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Corneel Heymanslaan 10, Building B, Entrance 36, 9000, Ghent, Belgium.
Louis Van der MeerenDepartment of Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.
Natasja Van den VrekenMedical Cell Biology Research Group, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Corneel Heymanslaan 10, Building B, Entrance 36, 9000, Ghent, Belgium.
Andre G SkirtachDepartment of Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.
Sanjay SinhaWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Julie De BackerCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Jolanda van HengelMedical Cell Biology Research Group, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Corneel Heymanslaan 10, Building B, Entrance 36, 9000, Ghent, Belgium. Jolanda.vanhengel@ugent.be.ORCID http://orcid.org/0000-0003-0645-0435
Ghent University · BEGhent University Hospital · BEWellcome/MRC Cambridge Stem Cell Institute · GB

Funding

British Heart Foundation FS/18/46/33663British Heart Foundation RG/17/5/32936Medical Research Council MC_PC_12009Medical Research Council MC_PC_17230
6 · The paper itself

Abstract

Marfan syndrome (MFS) is a systemic disorder of connective tissue caused by pathogenic variants in the fibrillin-1 (FBN1) gene. Myocardial dysfunction has been demonstrated in MFS patients and mouse models, but little is known about the intrinsic effect on the cardiomyocytes (CMs). In this study, both induced pluripotent stem cells derived from a MFS-patient and the line with the corrected FBN1 mutation were differentiated to CMs. Several functional analyses are performed on this model to study MFS related cardiomyopathy. Atomic force microscopy revealed that MFS CMs are stiffer compared to corrected CMs. The contraction amplitude of MFS CMs is decreased compared to corrected CMs. Under normal culture conditions, MFS CMs show a lower beat-to-beat variability compared to corrected CMs using multi electrode array. Isoproterenol-induced stress or cyclic strain demonstrates lack of support from the matrix in MFS CMs. This study reports the first cardiac cell culture model for MFS, revealing abnormalities in the behavior of MFS CMs that are related to matrix defects. Based on these results, we postulate that impaired support from the extracellular environment plays a key role in the improper functioning of CMs in MFS.

Indexed as

MutationAdultCell DifferentiationFibrillinsHumansInduced Pluripotent Stem CellsMarfan SyndromeMyocytes, CardiacFibrillins

Identifiers

PMID33028885
PMCPMC7542175
OpenAlexW3091922950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.